Park Square is pleased to announce the placement of Dr. Alicia Chung as Senior Vice President, Strategy and Business Development at Bionaut Labs, a company that is revolutionizing the treatment of central nervous system disorders with its precision medicine treatment modality.

Chung most recently served as Head of Corporate Development at Amphivena Therapeutics. Previously, she served as Associate Director, Business Development and Strategy at Halozyme Therapeutics. Earlier, she spent nine years at Genentech/Roche in roles of increasing responsibility in business development, strategy, and global medical affairs.

Chung holds a Ph.D. in Cell Biology and Biochemistry from Brown University and a B.S. in Neuroscience from University of California, Davis.

Chung is the third executive whom Park Square has placed at Bionaut Labs as the company continues to grow and scale.